OXFORD BIOMEDICA (OXB): MODERATED CHART AND DISCUSSION THREAD

HB, on 8th Dec OXB stated:

Oxford BioMedica has a key strategic objective of securing a major corporate
partner for the ongoing development and commercialisation of TroVax. The Company
has progressed to negotiations of terms with its lead prospective partners and
remains committed to finalising a deal expeditiously.

Until this point there had been four in various stages of DD. Now it seems reasonable to assume that four are/were in final negotiations.

Hopefully expeditiously means early in the new year.